Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures

Bisphosphonate Use and Atypical Fractures of the Femoral Shaft

(2011) Jörg Schilcher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: What we think we know and what we know that we don't know

(2010) Matthew R. Allen et al.   BONE

Mineral heterogeneity affects predictions of intratrabecular stress and strain

(2010) G.A.P. Renders et al.   JOURNAL OF BIOMECHANICS

Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research

(2010) Elizabeth Shane et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur

(2010) Dennis M. Black et al.   NEW ENGLAND JOURNAL OF MEDICINE

Trabecular packet-level lamellar density patterns differ by fracture status and bone formation rate in white females

(2009) Traci E. Ciarelli et al.   BONE

Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity

(2009) Samuel Gourion-Arsiquaud et al.   BONE

Use of FTIR Spectroscopic Imaging to Identify Parameters Associated With Fragility Fracture

(2009) Samuel Gourion-Arsiquaud et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of 1 to 3 years' treatment with alendronate on mechanical properties of the femoral shaft in a canine model: Implications for subtrochanteric femoral fracture risk

(2009) David B. Burr et al.   JOURNAL OF ORTHOPAEDIC RESEARCH

Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs

(2008) M. Saito et al.   OSTEOPOROSIS INTERNATIONAL

Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate

(2008) S. Y. Tang et al.   OSTEOPOROSIS INTERNATIONAL

Spectroscopic markers of bone quality in alendronate-treated postmenopausal women

(2008) A. L. Boskey et al.   OSTEOPOROSIS INTERNATIONAL